<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Alwis, Ruklanthi de</dc:creator>
  <dc:creator>Beltramello, Martina</dc:creator>
  <dc:creator>Messer, William B.</dc:creator>
  <dc:creator>Sukupolvi-Petty, Soila</dc:creator>
  <dc:creator>Wahala, Wahala M. P. B.</dc:creator>
  <dc:creator>Kraus, Annette</dc:creator>
  <dc:creator>Olivarez, Nicholas P.</dc:creator>
  <dc:creator>Pham, Quang</dc:creator>
  <dc:creator>Brian, James</dc:creator>
  <dc:creator>Tsai, Wen-Yang</dc:creator>
  <dc:creator>Wang, Wei-Kung</dc:creator>
  <dc:creator>Halstead, Scott</dc:creator>
  <dc:creator>Kliks, Srisakul</dc:creator>
  <dc:creator>Diamond, Michael S.</dc:creator>
  <dc:creator>Baric, Ralph</dc:creator>
  <dc:creator>Lanzavecchia, Antonio</dc:creator>
  <dc:creator>Sallusto, Federica</dc:creator>
  <dc:creator>Silva, Aravinda M. de</dc:creator>
  <dc:date>2011-06-21</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Humans who experience a primary dengue virus (DENV) infection develop antibodies that  preferentially neutralize the homologous serotype responsible for infection. Affected  individuals also generate cross-reactive antibodies against heterologous DENV serotypes,  which are non-neutralizing. Dengue cross-reactive, non-neutralizing antibodies can enhance  infection of Fc receptor bearing cells and, potentially, exacerbate disease. The actual binding  sites of human antibody on the DENV particle are not well defined. We characterized the  specificity and neutralization potency of polyclonal serum antibodies and memory B-cell  derived monoclonal antibodies (hMAbs) from 2 individuals exposed to primary DENV  infections. Most DENV-specific hMAbs were serotype cross-reactive and weakly neutralizing.  Moreover, many hMAbs bound to the viral pre-membrane protein and other sites on the virus  that were not preserved when the viral envelope protein was produced as a soluble,  recombinant antigen (rE protein). Nonetheless, by modifying the screening procedure to detect  rare antibodies that bound to rE, we were able to isolate and map human antibodies that  strongly neutralized the homologous serotype of DENV. Our MAbs results indicate that, in  these two individuals exposed to primary DENV infections, a small fraction of the total  antibody response was responsible for virus neutralization.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://susi.usi.ch/global/documents/318915</dc:identifier>
  <dc:identifier>https://localhost:5000/ark:/12658/srd1318915</dc:identifier>
  <dc:identifier>https://susi.usi.ch/documents/318915/files/deAlwis_PNTD_2011.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1371/journal.pntd.0001188</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/ark/12658/srd1318915</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>CC BY</dc:rights>
  <dc:source>Plos neglected tropical diseases. - 2011, vol. 5, no. 6, p. e1188</dc:source>
  <dc:subject>info:eu-repo/classification/udc/61</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
